Sjögren's Syndrome in Systemic Sclerosis: A Clinical Study of 26 Patients

References

• Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca (keratis filiformis in Hypofunktion der Tränendrüsen). Acta Ophthal 1933–41; 11–12(suppl 2)1–151
   Google Scholar
• Bloch K J, Buchanan W W, Wohl M J, et al. Sjögren's syndrome: a clinical pathological and serological study of sixty-two cases. Medicine (Baltimore) 1965; 44: 187–231
   PubMed Web of Science ®Google Scholar
• Shearn M A. The Sjögren-Mikulicz syndrome. Calif Med 1961; 95: 159–62
   PubMedGoogle Scholar
• Heaton J M. Sjögren's syndrome and systemic lupus erythematosis. Br Med J 1959; i: 466–9
   Google Scholar
• Steinberg A D, Talal N. The coexistence of Sjögren's syndrome and systemic lupus erythematosis. Ann Int Med 1971; 74: 55–61
   PubMed Web of Science ®Google Scholar
• Whaley K, Williamson J, Chisholm D M, Mason D K, Buchanan W W. Sjögren's syndrome. I, Sicca components. Q J Med 1973; 42: 279–304
   PubMedGoogle Scholar
• Whaley K, Webb J, McAvoy B A, Hughes G RV, Lee P, MacSween R NM, Buchanan W W. Sjögren's syndrome. II, Clinical associations and immuno-pathological phenomena. Q J Med 1973; 42: 513–48
   PubMedGoogle Scholar
• Grennan D M, Forrester J. Involvement of the eye in SLE and scleroderma. A study using fluorescein angiography in addition to clinical ophthalmic assessment. Ann Rheum Dis 1977; 36: 152–6
   PubMed Web of Science ®Google Scholar
• Alarçon-Segovia D. Symptomatic Sjögren's syndrome in mixed connective tissue disease. J Rheumatol 1976; 3: 191–6
   PubMed Web of Science ®Google Scholar
• Ramirez Peredo J. Sjögren's syndrome in Behçet disease. Lancet 1973; ii: 732
   Google Scholar
• Lawley T J, Peck G L, Moutsopoulos H M, Gratwohl A A, Diesseroth A B. Scleroderma, Sjögrenlike syndrome, and graft-versus-host disease. Ann Intern Med 1977; 87: 707–9
   PubMedGoogle Scholar
• Gratwohl A A, Moutsopoulos H M, Chused T M, Akizuki M, Wolf R O, Sweet J B, Deisseroth A B. Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977; 87: 703–6
   PubMed Web of Science ®Google Scholar
• Stava Z. Diffuse scleroderma a clinical study of sixty-five cases. Dermatologica Basel 1958; 117: 135–47
   PubMedGoogle Scholar
• Shearn M A. Sjögren's syndrome in association with scleroderma. Ann Int Med 1960; 52: 1352–61
   PubMedGoogle Scholar
• Tuffanelli D L, Winkelmann R K. Systemic scleroderma, a clinical study of 727 cases. Arch Derm (Chicago) 1961; 84: 359–71
   PubMedGoogle Scholar
• Tuffanelli D L, Winkelmann R K. Scleroderma and its relationship to the “collagenoses” dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome. Am J Med Sciences 1962; 133–46
   PubMedGoogle Scholar
• Horan E C. Ophthalmic manifestations of progressive systemic sclerosis. Br J Ophthal 1969; 53: 388–92
   PubMed Web of Science ®Google Scholar
• Kirkham T H. Scleroderma and Sjögren's syndrome. Br J Ophthal 1969; 53: 131–3
   PubMed Web of Science ®Google Scholar
• Camus J P, Emerit J, Reinert Ph, et al. Sclérodermie familiale avec syndrome de Sjögren et anomalies lymphocytaires et chromosomiques. Ann Med Internes 1970; 121: 149–61
   PubMedGoogle Scholar
• Chisholm D M, Waterhouse J P, Mason D K. Lymphocytic sialadenitis in major and minor glands: a correlation in post mortem subjects. J Clin Pathol 1970; 23: 690–4
   PubMed Web of Science ®Google Scholar
• Alarçon-Segovia D, Ibanez G, Hernandez-Ortis J, et al. Sjögren's syndrome in progressive systemic sclerosis (Scleroderma). Am J Med 1974; 57: 78–85
   PubMedGoogle Scholar
• Fiessinger J N, Blancet-Bardon C, Drouillat J P, et al. Rapports entre la sclérodermie et le syndrome de Sjögren. Intérêt de la biopsie systématique des glandes salivaires labiales. Nouv Pr Med 1975; 4: 3177–80
   PubMedGoogle Scholar
• Cipoletti J F, Buckingham R B, Barnes E L, et al. Sjögren's syndrome in progressive systemic sclerosis. Ann Int Med 1977; 87: 535–41
   PubMedGoogle Scholar
• Osial T HA, Whiteside T HL, Buckingham R B, et al. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983; 26: 500–8
   PubMedGoogle Scholar
• Alexander E L, Hirsch T HJ, Arnett F S, et al. RO (SSA) and La (SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol 1982; 9: 239–46
   PubMed Web of Science ®Google Scholar
• Drosos A A, Andonopoulos A P, Costopoulos J S, Stavropoulos F D, Papadimitriou C S, Moutsopoulos H M. Sjögren's syndrome in progressive systemic sclerosis. J Rheumatol 1988; 15: 965–8
   PubMed Web of Science ®Google Scholar
• Masi A T, Rodnan G P, Medsger T HA, Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
   PubMed Web of Science ®Google Scholar
• Matthews R W, Bhoola K D, Rasker J J, Jayson M IV. Salivary secretion and connective tissue disease in man. Ann Rheum Dis 1985; 44: 20–6
   PubMedGoogle Scholar
• Henderson J W, Prough W A. Influence of age and sex on flow of tears. Arch Ophthal 1950; 43: 224–31
   PubMed Web of Science ®Google Scholar
• Williamson J, Whaley K, Dick W C, Anderson J A. Computer-assisted diagnosis in keratoconjunctivitis sicca. Churchill Livingstone Ltd. 1972; 148–52, Transaction of the ophthalmological societies of the United Kingdom. Vol XCI, Session 1971
   Google Scholar
• Schirmer O. Studien zur Physiologic und Pathologie der Tränenabsonderung und Tränenabfuhr. Arch Ophthal 1903; 56: 197–291
   Google Scholar
• van Bijsterveld O P. Diagnostic tests in the sicca syndrome. Arch Ophthal 1969; 82: 10–4
   PubMed Web of Science ®Google Scholar
• Williamson J, Cant S, Mason D K, Greig W R, Boyle J A. Sjögren's syndrome and thyroid disease. Br J Ophthalmol 1967; 51: 721–6
   PubMedGoogle Scholar
• Shearn M A. Sjögren's syndrome. WB Saunders, London, Toronto 1971
   Google Scholar
• Cummings N A. Oculocutaneous manifestations of rheumatic diseases. Rheumatology. Karger, Basel 1973; 60–97
   Google Scholar
• Schall G L, Anderson L S, Wolf R O, et al. Xerostomia in Sjögren's syndrome. Evaluation by sequential salivary scintigraphy. JAMA 1971; 216: 2104–16
   Google Scholar
• Johnson C, Shuster S. The abnormality of weat duct formation in psoriasis. Br J Dermatol 1969; 81: 846
   PubMedGoogle Scholar
• Alspaugh M A, Whaley K. Sjögren's syndrome, Chapter 62. Textbook of Rheumatology, W N Kelley. Saunders Company, London 1981
   Google Scholar
• Whaley K, Williamson J, Wilson T, et al. Sjögren's syndrome and auto-immunity in a geriatric population. Age Ageing 1972; 1: 197–206
   PubMedGoogle Scholar
• Manthorpe R, Oxholm P, Prause J U, Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986; 61(suppl)19–21
   Google Scholar
• Skopouli F N, Drosos A A, Papaioannou T, Moutsopoulos H M. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol 1986; 61(suppl)22–5
   Google Scholar
• Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol 1986; 61(suppl)26–7
   Google Scholar
• Fox R I, Robinson C, Curd J, Michelson P, Bone R, Howell F V. First international symposium on Sjögren's syndrome: suggested criteria for classification. Scand J Rheumatol 1986; 61(suppl)28–30
   Google Scholar
• Manthorpe R, Andersen V, Jensen O A, Oxholm P, Prause J U, Schiødt M. Editorial Comments to the four sets of criteria for Sjögren's syndrome. Scand J Rheumatol 1986; 61(suppl)31–5
   Google Scholar
• Prause J U, Manthorpe R, Oxholm P, Schiødt M. Definition and criteria for Sjögren's syndrome used by the contributors to the first international seminar on Sjögren's syndrome, 1986. Scand J Rheumatol 1986; 61(suppl)17–8
   Google Scholar
• Bloch K J, Bunim J J. Sjögren's syndrome and its relation to connective tissue diseases. J Chron Dis 1963; 16(suppl)915–27
   PubMedGoogle Scholar
• Alspaugh M A, Tan E M. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975; 55: 1067–73
   PubMed Web of Science ®Google Scholar
• Alspaugh M A, Buchanan W W, Whaley K. Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis and other organ and non-organ specific autoimmune diseases. Ann Rheum Dis 1978; 37: 244–6
   PubMedGoogle Scholar
• de Rooy D J, van de Putte L B, Habets W J, Verbeek A L, van Venrooy W J. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases. Scand J Rheumatol 1988; 17: 353–64
   PubMedGoogle Scholar
• Bernstein R M, Bunn C C, Hughes G R, Francoeur A M, Matthews M B. Cellular protein and RNA antigens in atoimmune disease. Mol Biol Med 1984; 2: 105–20
   PubMedGoogle Scholar
• Syrjanen S. Salivary glands in rheumatoid arthritis. Thesis, KuopioFinland 1982
   Google Scholar
• Lindahl G, Hedfors E. Focal lymphocytic infiltrates of salivary glands are not confined to Sjögren's syndrome. Scand J Rheumatol 1986; 161(suppl)52–5
   Google Scholar
• Damato B E, Allan D, Murray S B, Lee W R. Senile atrophy of the human lacrimal gland: The contribution of chronic inflammatory disease. Br J Ophthalmol 1984; 68: 674
   PubMed Web of Science ®Google Scholar
• Chisholm D M, Mason D K. Salivary gland function in Sjögren's syndrome. Br Dent J 1973; 135: 393–9
   PubMedGoogle Scholar